Trodelvy's active ingredient is sacituzumab govitecan-hziy. Trodelvy's inactive constituents include 2-(N-morpholino) ethane sulfonic acid (MES), polysorbate 80, and trehalose dihydrate. It is available in 180 and 200 mg doses and is used as needed. Due to its action method, Trodelvy has proven an effective treatment for breast cancer that is HER2- and HR-negative for both progesterone and estrogen receptors.
For more information about the trodelvy injection price in India, please call or text +91 9310090915